Water

Water

SCHEMBL188487

C[N+](c1ccccc1)(c1ccccc1)c1ccccc1.[OH-]

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQ

The experimentally established mechanism targets of Water. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APOBEC3A P31941 1/20 0.58
APOBEC3G Q9HC16 1/20 0.58
ALDH1A1 P00352 3/20 0.38
TDP1 Q9NUW8 3/20 0.38
KDM4E B2RXH2 1/20 0.38
TSHR P16473 6/20 0.37
ACHE P22303 4/20 0.37
LMNA P02545 1/20 0.37
ALOX12 P18054 1/20 0.37
CA4 P22748 2/20 0.32
TP53 P04637 1/20 0.32
CA1 P00915 2/20 0.30
CA2 P00918 2/20 0.30
CA9 Q16790 2/20 0.30
CA12 O43570 1/20 0.30
GLA P06280 1/20 0.30
CA3 P07451 1/20 0.30
CA14 Q9ULX7 1/20 0.30
OPRM1 P35372 1/20 0.30
CA7 P43166 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2230404 0.97 APOBEC3A (0.61) APOBEC3AAPOBEC3GALDH1A1TDP1KDM4E
Iodide SCHEMBL240324 0.93 APOBEC3A (0.67) APOBEC3AAPOBEC3GALDH1A1TDP1KDM4E
Fluoride Ion SCHEMBL1502846 0.93 APOBEC3A (0.58) APOBEC3AAPOBEC3GALDH1A1TDP1KDM4E
Bromide SCHEMBL239525 0.93 APOBEC3A (0.58) APOBEC3AAPOBEC3GALDH1A1TDP1KDM4E
Hydrochloric Acid SCHEMBL236927 0.93 APOBEC3A (0.58) APOBEC3AAPOBEC3GALDH1A1TDP1KDM4E
Bromide SCHEMBL14972598 0.88 APOBEC3A (0.52) APOBEC3AAPOBEC3GALDH1A1TDP1KDM4E
SCHEMBL27734056 0.85 APOBEC3A (0.50) APOBEC3AAPOBEC3GALDH1A1TDP1KDM4E
SCHEMBL2150488 0.85 APOBEC3A (0.50) APOBEC3AAPOBEC3GALDH1A1TDP1KDM4E
SCHEMBL27817432 0.83 APOBEC3A (0.48) APOBEC3AAPOBEC3GALDH1A1TDP1KDM4E
Perchlorate SCHEMBL2149836 0.81 APOBEC3A (0.46) APOBEC3AAPOBEC3GALDH1A1TDP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 514 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101248516-A Selective wet etching of metal nitrides SACHEM INC (US) 2008-08-20 CN claimed
EP-1866957-A1 SELECTIVE WET ETCHING OF METAL NITRIDES SACHEM, INC. (US) 2007-12-19 EP claimed
WO-2006110279-A1 SELECTIVE WET ETCHING OF METAL NITRIDES SACHEM, INC. (US) 2006-10-19 WO claimed
US-20060226122-A1 Selective wet etching of metal nitrides NATIONAL CITY BANK, AS AGENT 2006-10-12 US claimed
CN-122037155-A Hollow container and method for producing polycarbonate resin 三菱化学株式会社 2026-05-15 CN disclosed
EP-2371877-B1 POLYCARBONATE RESIN, POLYCARBONATE RESIN COMPOSITION, OPTICAL FILM, AND POLYCARBONATE RESIN MOLDED ARTICLE MITSUBISHI CHEM CORP (JP) 2026-04-29 EP disclosed
US-20260098129-A1 THERMOPLASTIC RESIN AND MOLDED BODY CONTAINING THERMOPLASTIC RESIN MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2026-04-09 US disclosed
US-20260071030-A1 THERMOPLASTIC RESIN, MOLDED BODY CONTAINING THERMOPLASTIC RESIN, AND OPTICAL LENS MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2026-03-12 US disclosed
US-20260062520-A1 THERMOPLASTIC RESIN AND MOLDED OBJECT INCLUDING THERMOPLASTIC RESIN MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2026-03-05 US disclosed
EP-4129965-B1 THERMOPLASTIC RESIN HAVING CARBONATE BOND MITSUBISHI CHEM CORP (JP) 2025-12-17 EP disclosed
EP-4631991-A1 THERMOPLASTIC RESIN AND MOLDED BODY CONTAINING THERMOPLASTIC RESIN MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2025-10-15 EP disclosed
EP-4631995-A1 THERMOPLASTIC RESIN, MOLDED BODY CONTAINING THERMOPLASTIC RESIN, AND OPTICAL LENS MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2025-10-15 EP disclosed
US-4374042-A QUATERNARY AMMONIUM COMPOUND AND AN ORGANIC IONIC COMPOUND UOP INC. (US) 1983-02-15 US disclosed
US-4360421-A Method for treating mercaptans contained in a sour petroleum distillate UOP INC. (US) 1982-11-23 US disclosed
US-4320029-A Catalytic composite, method of manufacture, and process for use UOP INC. (US) 1982-03-16 US disclosed
US-4308169-A TREATMENT WITH AQUEOUS SOLUTION OF QUATERNARY AMMONIUM COMPOUND AND LINEAR IONIC COMPOUND UOP INC. (US) 1981-12-29 US disclosed
US-4299729-A TREATING WITH AN AMMONIACAL SOLUTION OF A METAL CHELATE AND AN AQUEOUS SOLUTION OF A QUATERNARY AMMONIUM COMPOUND UOP INC. (US) 1981-11-10 US disclosed
US-4298463-A Method of treating a sour petroleum distillate UOP INC. (US) 1981-11-03 US disclosed
US-4213877-A Method of reactivating a catalytic composite of an adsorptive carrier material and a mercaptan oxidation catalyst UOP INC. (US) 1980-07-22 US disclosed
US-4203827-A Process for treating sour petroleum distillates UOP INC. (US) 1980-05-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260062520-A1 THERMOPLASTIC RESIN AND MOLDED OBJECT INCLUDING THERMOPLASTIC RESIN RER1, PUF60, SEM1 APOBEC3A 2188/4885APOBEC3G 2592/4885ALDH1A1 116/4885
US-20260071030-A1 THERMOPLASTIC RESIN, MOLDED BODY CONTAINING THERMOPLASTIC RESIN, AND OPTICAL LENS DERL1, WDR1, RIF1 APOBEC3A 3808/4885APOBEC3G 4009/4885ALDH1A1 521/4885
US-20260098129-A1 THERMOPLASTIC RESIN AND MOLDED BODY CONTAINING THERMOPLASTIC RESIN RER1, EIF2AK1, RIOK1 APOBEC3A 2856/4885APOBEC3G 3576/4885ALDH1A1 46/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.